Skip to content

DE VULDER

Active
Private limited companyfounded 200917 yrs activeKerkstraat 16, 1761 Roosdaal, BelgiumKBO/BCE: BE 0811.979.773
Summary

DE VULDER has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €78k and a net result of €61k. Equity remains stable across the filed fiscal years (±0.3% per year). Its solvency ranks better than 16% of 9623 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.7% (low).

Checked score

Score 2024
56 / 100
Fair
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability77▼-4
Solvency34=
Growth52=
Track record100
Bankruptcy probability, 12 months
0.7% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €4k at 30 days acceptable
Liquidity short (current ratio 0.7 against 0.69 in 2023; short-term debt: 67.3% and cash: 10.3% of total assets), and 91.2% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Four signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 17 years 0 20 y
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 16% of 9623 sector peers (2024).
NBB · sector comparison
Position among 9623 sector peers
Solvency
better than 16%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 20-06-2025, 41 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
not confirmed
2024
41 d early
2023
29 d late
2022
6 d early
2021
29 d late
2020
24 d late
2019
53 d late
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2024, abbreviated schema

Equity
€78k▲ 0.2%
2023 · €78k
2018: €77k 2019: €77k 2020: €78k 2021: €78k 2022: €78k 2023: €78k
2018 → 2024
Total assets
€888k▲ 0.9%
2023 · €880k
2018: €1.06M 2019: €1.07M 2020: €1.08M 2021: €1.08M 2022: €975k 2023: €880k
2018 → 2024
Net result
€61k▼ 28.5%
2023 · €86k
2018: €100k 2019: €64k 2020: €63k 2021: €109k 2022: €70k 2023: €86k
2018 → 2024
Working capital
€-180k▼ 3.2%
2023 · €-174k
2018: €-156k 2019: €-159k 2020: €-157k 2021: €-157k 2022: €-160k 2023: €-174k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20202021202220232024Trend
Equity€78k-€78k▲ 0.7%€78k▲ 0.1%€78k=€78k▲ 0.2%
Operating result€30k-€123k▲ 308%€82k▼ 33.3%€97k▲ 18.8%€90k▼ 7.6%
Net result€63k-€109k▲ 71.1%€70k▼ 35.4%€86k▲ 22.1%€61k▼ 28.5%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100kOperating result 2020: €30k€30kNet result 2020: €63k€63kOperating result 2021: €123k€123kNet result 2021: €109k€109kOperating result 2022: €82k€82kNet result 2022: €70k€70kOperating result 2023: €97k€97kNet result 2023: €86k€86kOperating result 2024: €90k€90kNet result 2024: €61k€61k20202021202220232024€0€25k€50k€75k€100kOperating result 2022: €82k€82kNet result 2022: €70k€70kOperating result 2023: €97k€97kNet result 2023: €86k€86kOperating result 2024: €90k€90kNet result 2024: €61k€61k202220232024
The operating result falls in 2024; 2024 is 8% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €888k
Fixed assets €470k ▼ 4.3%
Current assets €418k ▲ 7.4%
Equity and liabilities €888k
Equity €78k ▲ 0.2%
Debt €810k ▲ 1.0%
Debt's share of the balance-sheet total rises from 91.1% to 91.2%. Equity and debt are higher.
Key figures and ratios
2024 value · change against 2023
EBITDA
€119k
2023 · €126k
Cash flow
€90k
2023 · €114k
Current ratio
0.70
2023 · 0.69
Quick ratio
0.32
2023 · 0.27
Debt to equity
10.35
2023 · 10.27
ROE
78.2%
2023 · 109.5%
ROA
6.9%
2023 · 9.7%
Interest coverage
11.28
2023 · 11.03
Debt ≤ 1 year
€597k
2023 · €563k
Debt > 1 year
€211k
2023 · €238k
Income taxes
€18k
2023 · €651
Staff costs
€76k
2023 · €74k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 54 lines
Balance sheet Code20232024
Assets
Total assets20/58€880k€888k
Fixed assets21/28€491k€470k
Tangible fixed assets22/27€491k€470k
Land and buildings22€453k€430k
Plant, machinery and equipment23€8k€10k
Furniture and vehicles24€30k€30k
Current assets29/58€389k€418k
Stocks and contracts in progress3€238k€228k
Stocks30/36€238k€228k
Amounts receivable within one year40/41€84k€96k
Trade receivables40€80k€89k
Other amounts receivable41€4k€7k
Cash at bank and in hand54/58€66k€91k
Deferred charges and accrued income490/1€105€2k
Equity and liabilities
Total equity and liabilities10/49€880k€888k
Equity10/15€78k€78k
Contributions10/11€6k€6k=
Reserves13€72k€72k
Non-distributable reserves130/1€0-
Reserves not available under the articles1311€0-
Distributable reserves133€72k€72k
Profit (loss) carried forward14€0€0=
Amounts payable17/49€802k€810k
Amounts payable after more than one year17€238k€211k
Financial debts170/4€238k€211k
Amounts payable within one year42/48€563k€597k
Current portion of amounts payable after more than one year42€26k€26k
Trade debts44€144k€155k
Suppliers440/4€144k€155k
Taxes, remuneration and social security45€14k€13k
Taxes450/3€651€651=
Remuneration and social security454/9€13k€13k
Other amounts payable47/48€379k€402k
Accrued charges and deferred income492/3€987€790
Income statement Code20232024
Remuneration, social security and pensions62€74k€76k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€28k€29k
Other operating charges640/8€4k€4k
Gross operating margin9900€203k€199k
Operating profit (loss)9901€97k€90k
Financial income75/76B€340€226
Recurring financial income75€340€226
Financial charges65/66B€11k€11k
Recurring financial charges65€11k€11k
Profit (loss) for the period before taxes9903€86k€80k
Income taxes67/77€651€18k
Profit (loss) for the period9904€86k€61k
Profit (loss) for the period to be appropriated9905€86k€61k
Appropriation of the result
Profit (loss) to be appropriated9906€86k€61k
Transfer to equity691/2€23€146
To other reserves6921€23€146
Profit to be distributed694/7€86k€61k
Return on contributions (dividend)694-€53k
Directors or managers695€86k€8k
Social balance
Average headcount (FTE)90871.01.0=

The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

2025
20-06
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial Weakest financial yearnet €61k ▼28.5%
Net result drops to €61k, the lowest in the series.
29-08
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema · 29 days late
2023
25-07
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
29-08
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema · 29 days late
2021
31-12
Financial Highest result since 2018net €109k ▲71.1%
Operating result €123k, net result €109k, both a record.
24-08
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema · 24 days late
2020
22-09
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema · 53 days late
2019
29-08
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema · 29 days late
2018
18-07
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
29-08
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema · 29 days late
2016
19-07
NBB filing Annual accounts filed
fiscal year 2015 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Roosdaal · 1 establishment unit since 2009
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Kerkstraat 161761 Roosdaal
Ground area
856 m²
Building footprint
176 m²
Volume, LiDAR
874 m³
Parcel 23011A0249/00X000, Flanders · tallest building 10.2 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
DE VULDER
Kerkstraat 16, 1761 RoosdaalManufacture of basic pharmaceutical products and pharmaceutical preparations
since 20092.178.413.528
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
23011A0249/00X000 Flanders 856 m² 1 · 176 m² 10.2 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,226 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded29-05-2009
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 16 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.